News

Tetraneuron receives the Innovative SME Seal from the Ministry of Science and Innovation.

The Ministry recognizes the innovation present in Tetraneutron’s research and developments within the field of Alzheimer’s disease. Additionally, Tetraneuron advance in the regulatory roadmap with its innovative therapy.   Madrid, September 7, 2021.- Tetraneuron, a biotech company developing a multifactorial genetic therapy against the Alzheimer’s disease, announced the obtention of…